Therapeutic potential of NOX inhibitors in neuropsychiatric disorders.

Parneet Kaur, Heena Khan, Amarjot Kaur Grewal, Kamal Dua, Thakur Gurjeet Singh

Psychopharmacology 2023 Sep

filter terms:

Neuropsychiatric disorders encompass a broad category of medical conditions that include both neurology as well as psychiatry such as major depressive disorder, autism spectrum disorder, bipolar disorder, schizophrenia as well as psychosis. NADPH-oxidase (NOX), which is the free radical generator, plays a substantial part in oxidative stress in neuropsychiatric disorders. It is thought that elevated oxidative stress as well as neuroinflammation plays a part in the emergence of neuropsychiatric disorders. Including two linked with membranes and four with subunits of cytosol, NOX is a complex of multiple subunits. NOX has been linked to a significant source of reactive oxygen species in the brain. NOX has been shown to control memory processing and neural signaling. However, excessive NOX production has been linked to cardiovascular disorders, CNS degeneration, and neurotoxicity. The increase in NOX leads to the progression of neuropsychiatric disorders. Our review mainly emphasized the characteristics of NOX and its various mechanisms, the modulation of NOX in various neuropsychiatric disorders, and various studies supporting the fact that NOX might be the potential therapeutic target for neuropsychiatric disorders. Here, we summarizes various pharmacological studies involving NOX inhibitors in neuropsychiatric disorders. © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Citation

Parneet Kaur, Heena Khan, Amarjot Kaur Grewal, Kamal Dua, Thakur Gurjeet Singh. Therapeutic potential of NOX inhibitors in neuropsychiatric disorders. Psychopharmacology. 2023 Sep;240(9):1825-1840